Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_provenance.
• NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343874.RAZdvGowTvgY4ag3-gIOCXFCmrVCmM_xV30T3j-ug-9DM130_provenance.
• NP80331.RAaQ3JUhQwiyR0SKQv3RjkcZ-uVOR1r3HGb9A8ip83Sdk130_assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80331.RAaQ3JUhQwiyR0SKQv3RjkcZ-uVOR1r3HGb9A8ip83Sdk130_provenance.
• NP77289.RAjKeL8yiRABXgwS8sj9jC5lDW9kE8NG2Qtrb5uR9_ZiI130_assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77289.RAjKeL8yiRABXgwS8sj9jC5lDW9kE8NG2Qtrb5uR9_ZiI130_provenance.
• NP399208.RAQfa9XtkObcftGtrSTffI8LhyGwbQ8Ug51yoPVu6HTvY130_assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP399208.RAQfa9XtkObcftGtrSTffI8LhyGwbQ8Ug51yoPVu6HTvY130_provenance.
• NP343775.RAoUmyWSfjvs665J-QF9LD4dzxvRn02IKStqRDFxQMgbE130_assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343775.RAoUmyWSfjvs665J-QF9LD4dzxvRn02IKStqRDFxQMgbE130_provenance.
• NP399207.RAru2aOLbLtigbzianAjAhK6bs8ragkb0OuSvLjMvX4OU130_assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP399207.RAru2aOLbLtigbzianAjAhK6bs8ragkb0OuSvLjMvX4OU130_provenance.
• NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_provenance.
• NP77286.RA0rkPjaia3oGoVdNc9gM6qEIQzpIrXQzT1V53i4tIlTU130_assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77286.RA0rkPjaia3oGoVdNc9gM6qEIQzpIrXQzT1V53i4tIlTU130_provenance.
• NP80330.RA3xRdXDpKX9-IJEsojNk5SCvXmDs8HmOg6NYFLy0Tubo130_assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80330.RA3xRdXDpKX9-IJEsojNk5SCvXmDs8HmOg6NYFLy0Tubo130_provenance.